IGF2 and hepatocellular carcinoma: It was suggested that miR-1275 acts as a tumour suppressor in several types of cancers [30–33], and miR-1275 overexpression has been reported to inhibit malignant cell behaviours and proliferation in hepatocellular carcinoma simultaneously by regulating oncogenic insulin-like growth factor-2 [30–32].